ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway

Abstract

Background Malignant melanoma (MM) is highly metastatic and has the highest mortality rate in patients with skin cancer. The ERBB3 binding protein 1 (Ebp1) has been linked to the onset and progression of a number of malignancies. However, the role of Ebp1 in MM has not yet been reported. Methods Multiple databases were analyzed for comparing the expression of Ebp1 in normal skin and MM. Ebp1 expression was knocked down in A375 and B16 cells, and the impact of Ebp1 on the cell growth was tested by CCK-8, plate clone colony, and cell cycle assays. Scratch, transwell, and in vivo caudal vein lung metastasis tests were also used to confirm the effects of Ebp1 on melanoma cells migration, invasion, and metastasis. Furthermore, the possible molecular mechanism of Ebp1 was predicted by set enrichment analysis and verified by western blotting. Results Ebp1 expression was substantially higher in MM than it was in normal skin, and Ebp1 was linked to the clinical stage and lymph node metastases of patients with MM. Knockdown of Ebp1 inhibited cell proliferation, migration, and invasion. In vivo experiments further verified that the knockdown of Ebp1 had an obvious inhibitory effect on lung metastasis in nude mice. Knockdown of Ebp1 reduced vimentin, N-cadherin, slug, and snail expression while increasing E-cadherin expression. Furthermore, knockdown of Ebp1 reduced the expression of β-catenin, as well as its downstream targets CyclinD1 and p-GSK3β; however, a Wnt/β-catenin agonist could reverse this effect. Conclusion Ebp1 may promote the proliferation and metastasis of melanoma cells through activation of the Wnt/β-catenin pathway. Graphical Abstract

A de novo dual-targeting supramolecular self-assembly peptide against pulmonary metastasis of melanoma

“…Several recent studies have pointed out that the Wnt/β-catenin and MAPK signaling pathways are critical contributors to the metastasis of melanoma [9][10][11][12][13][14][15]. The over-accumulation of β-catenin promotes the development of melanoma and melanoma lung metastases through activation of the classical Wnt pathway, and it has been confirmed that inhibiting Wnt/β-catenin can reduce the probability of melanoma lung metastase [9,11,[16][17][18].…”